Searched for
TARIFF RELIEF PHARMACEUTICALS
Why did market rise today? Sensex rallied 791 pts, Nifty closed above 24,000; 6 key factors drove D-St reboundIndian stock markets witnessed a significant surge today, with Sensex and Nifty climbing up to 1%. This positive momentum was fueled by the...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- UK exports to US slump as tariffs bite: Official dataBritish exports to the United States have fallen significantly following the imposition of US tariffs. The value of goods exported to the U...
- Why US stock market surging big today on final day of April? Dow Jones, S&P 500 and Nasdaq all in green as Dow jumps record 500 points — Nvidia, Intel and Meta Platforms stocks crashUS stock market surging big today. Dow Jones, S&P 500 and Nasdaq rally as Dow jumps record 500 points. A powerful mix of blowout earnings, ...
- Trump unveils deal with Regeneron to lower drug prices as part of most-favored-nation initiativeRegeneron will reduce prices for its drugs on Medicaid. A cholesterol drug, Praluent, will be available for USD 225 on Trump's discounted d...
- SEZ units can sell locally at lower duty for one yearIndia has announced a one-time relief for Special Economic Zone (SEZ) units, allowing them to sell goods in the domestic market at a lower ...
- India allows export zones to sell locally as trade strains growThis measure, effective from April 2026 to March 2027, aims to help exporters manage rising tariffs and supply chain disruptions caused by ...
- India-US trade deal: Forging a new economic eraFor India, the primary benefit is a significant reduction in US reciprocal tariffs and durable relief from certain national security-relate...
- From drugs to aircraft parts, what India gets under the $500 billion US trade dealIndia and the US have agreed on an interim trade framework, improving Indian market access for pharmaceuticals, gems, diamonds, and aircraf...
- Trump sees India trade deal soon, but will tariff hammer still loom?US President Donald Trump signals a trade deal with India is coming soon. This offers hope for Indian exporters facing steep tariffs. Howev...
- Tariff pause eases pressure on drug companiesIndian drug makers can breathe easier as the US reportedly shelves plans for tariffs on generic drug imports. This move is a significant re...
- Trump & Co said to have shelved generic drug tariffs, Indian pharma stocks get booster doseThe Trump White House has halted plans for tariffs on generic drug imports, a decision welcomed by Indian pharma companies that supply near...
- Exporters to get 90% upfront refund only after GST law changeTo operationalize the GST Council's decision for 90% upfront refunds to exporters, a legal amendment is needed. The current GST Act lacks p...
- US lowers tariff on EU autos, implementing terms of dealThe United States has lowered tariffs on auto imports from the European Union to 15 percent, retroactive to August 1, following a trade pac...
- US, EU lock in trade deal; US official sees auto tariff relief in weeksThe United States and European Union have finalized a trade deal. The US will impose a 15% tariff on most EU imports. This includes autos, ...
- India-UK FTA prescribes a booster dose for Indian pharma and medtech exportsThe India-UK FTA is poised to significantly boost India's pharmaceutical and medical device sectors. Tariff relief and streamlined regulati...
- Duty relief to boost pharma companies' access to UK drug storesThe India-UK Free Trade Agreement is set to significantly benefit India's pharma and medical device industries. Tariff reductions and strea...
- Big relief for India! Trump spares pharma from harsh tariffsUS President Trump has exempted India's pharmaceuticals from new reciprocal tariffs, benefiting the major export industry. This exemption h...
- Pharma dodges Trump tariffs in first round but 3 scenarios are likely to haunt future prospectsIndia's pharmaceutical sector avoids immediate impact from newly declared tariffs on over 60 countries. However, HDFC Securities estimates ...
- 'For Modi, it's India first': Finance Ministry's Pankaj Chaudhary reacts to Trump tariffsIndia is evaluating the impact of the 27 per cent reciprocal tariffs imposed by the US on its goods. The assessment focuses on understandin...
Load More
